Increased signal intensity in the pulvinar on T1-weighted images: a pathognomonic MR imaging sign of Fabry disease
- PMID: 12812932
- PMCID: PMC8149001
Increased signal intensity in the pulvinar on T1-weighted images: a pathognomonic MR imaging sign of Fabry disease
Abstract
Background and purpose: Fabry disease is a multisystem X-linked disorder characterized clinically by angiokeratoma, corneal and lenticular abnormalities, acroparesthesia, and renal and cardiac dysfunction and stroke. We sought to describe novel neuroimaging characteristics of Fabry disease.
Methods: Neuroradiologic records of 104 hemizygous patients with Fabry disease evaluated between 1994 and 2002 were reviewed. In total, 94 MR studies consisting of T1- and T2-weighted images were examined for the presence of hyperintensity on the T1-weighted images. Additional CT, gradient-echo (T2*-weighted), and fat-suppression MR studies were reviewed to characterize further the T1 abnormality in selected patients. In some patients, cerebral blood flow (CBF) was quantified by using arterial spin tagging (AST).
Results: Overall, 22 patients ( approximately 23%) demonstrated pulvinar hyperintensity on T1-weighted images; the frequency increased with age to over 30% by age 50 years. Susceptibility-weighted T2* studies demonstrated a low-signal-intensity abnormality in the pulvinar in the more severe cases, whereas CT demonstrated the pulvinar to be mineralized. CT attenuation corresponded with an increasing signal intensity on T1-weighted images. Posterior circulation CBF was found to be elevated on individual AST studies, especially in the thalamus.
Conclusion: Hyperintensity in the pulvinar on T1-weighted images is a common finding in Fabry disease, likely reflecting the presence of calcification. Although other minreralizing abnormalities may result in calcification of deep gray nuclei, exclusive involvement of the pulvinar may be distinctively characteristic to Fabry disease. Increased CBF in the posterior circulation, particularly the thalamus, suggests that the dystrophic calcification is secondary to cerebral hyperperfusion and selective vulnerability of the pulvinar and adjacent thalamic nuclei. The finding of isolated pulvinar hyperintensity on T1-weighted images should suggest Fabry disease, particularly when seen in conjunction with other nonspecific neuroradiologic manifestations of the disease.
Figures





Similar articles
-
The pulvinar sign: frequency and clinical correlations in Fabry disease.J Neurol. 2008 May;255(5):738-44. doi: 10.1007/s00415-008-0786-x. Epub 2008 Feb 26. J Neurol. 2008. PMID: 18297328
-
T1 hyperintensity in the pulvinar: key imaging feature for diagnosis of Fabry disease.AJNR Am J Neuroradiol. 2003 May;24(5):916-21. AJNR Am J Neuroradiol. 2003. PMID: 12748094 Free PMC article.
-
Bilateral pulvinar signal intensity decrease on T2-weighted images in patients with aspartylglucosaminuria.Acta Radiol. 2008 Jul;49(6):687-92. doi: 10.1080/02841850802065000. Acta Radiol. 2008. PMID: 18568562
-
Neurological complications of Anderson-Fabry disease.Curr Pharm Des. 2013;19(33):6014-30. doi: 10.2174/13816128113199990387. Curr Pharm Des. 2013. PMID: 23448452 Review.
-
[Fabry disease in light of recent review].Brain Nerve. 2008 Nov;60(11):1235-44. Brain Nerve. 2008. PMID: 19069157 Review. Japanese.
Cited by
-
Region-specific susceptibility change in cognitively impaired patients with diabetes mellitus.PLoS One. 2018 Oct 11;13(10):e0205797. doi: 10.1371/journal.pone.0205797. eCollection 2018. PLoS One. 2018. PMID: 30308069 Free PMC article.
-
Increased resting cerebral blood flow in adult Fabry disease: MRI arterial spin labeling study.Neurology. 2018 Apr 17;90(16):e1379-e1385. doi: 10.1212/WNL.0000000000005330. Epub 2018 Mar 21. Neurology. 2018. PMID: 29661900 Free PMC article.
-
Hippocampal atrophy as a surrogate of neuronal involvement in Fabry disease.J Inherit Metab Dis. 2012 Mar;35(2):363-7. doi: 10.1007/s10545-011-9390-9. Epub 2011 Sep 20. J Inherit Metab Dis. 2012. PMID: 21932096
-
Fabry disease and early stroke.Stroke Res Treat. 2011;2011:615218. doi: 10.4061/2011/615218. Epub 2011 Jun 23. Stroke Res Treat. 2011. PMID: 21776363 Free PMC article.
-
Neurological diseases and pain.Brain. 2012 Feb;135(Pt 2):320-44. doi: 10.1093/brain/awr271. Epub 2011 Nov 8. Brain. 2012. PMID: 22067541 Free PMC article. Review.
References
-
- Anderson W. A case of angiokeratoma. Br J Dermat 1898;10:113
-
- Fabry J. Beitrag zur kenntnis de purpura hemorrhagica nodularis. Arch Dermatol Syph 1898;43:187
-
- Brady R, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L. Enzymatic defect in Fabry disease: ceramide trihexosidase deficiency. N Engl J Med 1967;276:1163–1167 - PubMed
-
- Desnick R, Ioannou YA, Eng CM. α-Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th ed.. New York: McGraw-Hill,2001. :3733–3774
-
- Jinkins J, da Costa Leite C. Neurodiagnostic Imaging: Pattern Analysis and Differential Diagnosis. Philadelphia: Lippincott-Raven,1998. :1130